GlassScriptPhysician profile
Vivian H Chou
NPI 1457573420
$10,357.34
in general payments reported to CMS, 2019-2025
38 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,192 · 2020: $248 · 2021: $1,074 · 2022: $2,143 · 2023: $1,996 · 2024: $2,242 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,613 · Education: $58.77 · Consulting Fee: $27.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,612.89 |
| Education | $58.77 |
| Consulting Fee | $27.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,014.56 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Genzyme Corporation | $1,154.00 | 2019-2025 | |
| Glaxosmithkline, LLC. | $958.47 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Regeneron Healthcare Solutions, INC. | $761.44 | 2021-2025 | Dupixent |
| Csl Behring | $583.74 | 2021-2025 | Kcentra, Haegarda, Hizentra |
| Pfizer INC. | $548.04 | 2019-2024 | |
| Covis Pharma Gmbh | $390.24 | 2019-2023 | |
| Biocryst US Sales Co., LLC | $348.01 | 2021-2025 | Orladeyo |
| Alk-Abello, INC | $305.19 | 2019-2024 | Grastek, Ragwitek, Odactra |
| Genentech USA, INC. | $288.81 | 2019-2025 | Xolair |
| Kaleo, INC. | $255.08 | 2019-2024 | Auvi-Q |
| Optinose US, INC. | $225.56 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $222.82 | 2021-2024 | Takhzyro, Cuvitru |
| Hospira, INC. | $210.89 | 2019-2025 | |
| Pharming Healthcare, INC. | $202.35 | 2020-2024 | Ruconest |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivian Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.